In 2011, Luo et al. revealed that negatively regulated AP-1 activity could lead to the decreasing mRNA level of cyclin D1 in gastric cancer cells27, which indicated that AP-1 might be involved in proliferation inhibition in gastric cancer. This evidence concerns the gene FOS and gastric cancer.